Next Article in Journal
Integrated -Omics: A Powerful Approach to Understanding the Heterogeneous Lignification of Fibre Crops
Next Article in Special Issue
Current Status of Biomarkers for Prostate Cancer
Previous Article in Journal
Mechanisms by Which Licochalcone E Exhibits Potent Anti-Inflammatory Properties: Studies with Phorbol Ester-Treated Mouse Skin and Lipopolysaccharide-Stimulated Murine Macrophages
Previous Article in Special Issue
The Genomic Landscape of Prostate Cancer
Article Menu

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2013, 14(6), 10944-10957;

Impact of an Altered Wnt1/β-Catenin Expression on Clinicopathology and Prognosis in Clear Cell Renal Cell Carcinoma

Department of Urology, Eberhard Karls University Tuebingen, Hoppe-Seyler Strasse 3, Tuebingen 72076, Germany
Institute of Pathology, Eberhard Karls University, Tuebingen 72076, Germany
Author to whom correspondence should be addressed.
Received: 14 March 2013 / Revised: 12 April 2013 / Accepted: 10 May 2013 / Published: 24 May 2013
(This article belongs to the Special Issue Molecular Research in Urology)
Full-Text   |   PDF [551 KB, uploaded 19 June 2014]


In renal cell carcinoma (RCC), single members of the Wnt/β-catenin signaling cascade were recently identified to contribute to cancer progression. However, the role of Wnt1, one of the key ligands in β-catenin regulation, is currently unknown in RCC. Therefore, alterations of the Wnt1/β-catenin axis in clear cell RCC (ccRCC) were examined with regard to clinicopathology, overall survival (OS) and cancer specific survival (CSS). Corresponding ccRCCs and benign renal tissue were analyzed in 278 patients for Wnt1 and β-catenin expression by immunohistochemistry in tissue microarrays. Expression scores, including intensity and percentage of stained cells, were compared between normal kidney and ccRCCs. Data was categorized according to mean expression scores and correlated to tumor and patients’ characteristics. Survival was analyzed according to the Kaplan-Meier and log-rank test. Univariable and multivariable Cox proportional hazard regression models were used to explore the independent prognostic value of Wnt1 and β-catenin. In ccRCCs, high Wnt1 was associated with increased tumor diameter, stage and vascular invasion (p ≤ 0.02). High membranous β-catenin was associated with advanced stage, vascular invasion and tumor necrosis (p ≤ 0.01). Higher diameter, stage, node involvement, grade, vascular invasion and sarcomatoid differentiation (p ≤ 0.01) were found in patients with high cytoplasmic β-catenin. Patients with a high cytoplasmic β-catenin had a significantly reduced OS (hazard ratio (HR) 1.75) and CSS (HR 2.26), which was not independently associated with OS and CSS after adjustment in the multivariable model. Increased ccRCC aggressiveness was reflected by an altered Wnt1/β-catenin signaling. Cytoplasmic β-catenin was identified as the most promising candidate associated with unfavorable clinicopathology and impaired survival. Nevertheless, the shift of membranous β-catenin to the cytoplasm with a subsequently increased nuclear expression, as shown for other malignancies, could not be demonstrated to be present in ccRCC. View Full-Text
Keywords: renal cell cancer; Wnt1; β-catenin; carcinogenesis; prognosis; targeted therapy renal cell cancer; Wnt1; β-catenin; carcinogenesis; prognosis; targeted therapy
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Kruck, S.; Eyrich, C.; Scharpf, M.; Sievert, K.-D.; Fend, F.; Stenzl, A.; Bedke, J. Impact of an Altered Wnt1/β-Catenin Expression on Clinicopathology and Prognosis in Clear Cell Renal Cell Carcinoma. Int. J. Mol. Sci. 2013, 14, 10944-10957.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top